TMCnet

First in Human Ischemic VT Ablation Successfully Performed in iCMR

Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR ), together with Amsterdam University Medical Centre ...
MarketWatch

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA ...

VASCEPA was associated with an increased risk (3% vs 2%) of atrial fibrillation or atrial flutter requiring hospitalization in a double-blind, placebo-controlled trial. The incidence of atrial ...

Imricor Medical Systems, Inc.: First in Human Ischemic VT Ablation Successfully Performed in iCMR

Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic ...
MedPage Today

Anticoagulant Alone Safer in Stroke Patients With Afib and Atherosclerosis

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...